Ï㽶ÊÓƵ

. McGill and its affiliated institutions have experts in the following areas of Alzheimer’s detection and treatment who are available to comment:

Ìý

Canadian Consortium on Neurodegeneration in Aging (CCNA)) based at the ÌýJewish General Hospital:Ìý

Early detection of AD through genetic and cognitive markers

Classified as: Alzheimer's disease (AD)
Category:
Published on: 18 Jan 2018

By Chris Chipello

Ï㽶ÊÓƵ researchers have discovered a cellular mechanism that may contribute to the breakdown of communication between neurons in Alzheimer’s disease.

Classified as: Alzheimer's, Alzheimer's disease (AD), Alzheimer’s research, neuron, brain tissue, faculty of medicine, science, medicine, staff, faculty, students, External
Category:
Published on: 13 Oct 2017

For years, neuroscientists have puzzled over how two abnormal proteins, called amyloid and tau, accumulate in the brain and damage it to cause Alzheimer's disease (AD). Which one is the driving force behind dementia? The answer: both of them, according to a new study by researchers at the Douglas Mental Health University Institute.

Classified as: Ï㽶ÊÓƵ, faculty of medicine, Douglas Mental Health University Institute, science and technology, Alzheimer's disease (AD), Dr. Pedro Rosa-Neto, neuroproject
Category:
Published on: 20 Apr 2016
Back to top